In this paper, we investigated the clinical significance of 18-F-FDG PET-CT SUVmax, NLR, PLR, LMR, and expression of GLUT1 and GLUT3, which can easily be measured in clinical settings, among various tumor metabolic activity and systemic inflammation markers, in patients with NSCLC. Here, SLC2A1 is linked to neoplasm.